Research Article
Effects of a Novel Glucokinase Activator, Dorzagliatin, on Glycemic Control and Glucose Fluctuation in Drug-Naïve Patients with Type 2 Diabetes Mellitus
Table 2
Glucose fluctuation parameters of the patients before and after intervention.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MBG: mean blood glucose (mmol/L); SDBG: standard deviation of mean blood glucose (mmol/L); MAGE: mean amplitude of glycemic excursions (mmol/L); LAGE: largest amplitude of glycemic excursions (mmol/L); ADRR: average daily risk range; LBGI: low blood glucose index; HGBI: high blood glucose index; TIR: time in range: percentage of time in the range of 3.9–10 mmol/L; TAR: time above range: percentage of time >10 mmol/L; TBR: time below range: percentage of time <3.9 mmol/L. Continuous variables with normal distribution were presented as mean ± SD; non-normal variables are shown as median (interquartile range). |